Despite the fact that interfering with ANXA3 alone could significantly inhibit tumor metastasis with and cause increased tumor growth unexpectedly in vivo, targeting ANXA3 in combination with doxorubicin therapy could inhibit tumor growth and metastasis simultaneously. This evidence concerns the gene ANXA3 and neoplasm.